Medirom Healthcare Technologies Inc
$ 1.33
-2.92%
24 Feb - close price
- Market Cap 10,825,700 USD
- Current Price $ 1.33
- High / Low $ 1.39 / 1.31
- Stock P/E 3.51
- Book Value 0.20
- EPS 0.39
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.02 %
- ROE 0.53 %
- 52 Week High 3.53
- 52 Week Low 0.34
About
MEDIROM Healthcare Technologies Inc. provides comprehensive healthcare services in Japan. The company is headquartered in Tokyo, Japan.
Analyst Target Price
$5.12
Quarterly Earnings
| Sep 2025 | Mar 2025 | Sep 2024 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-21 | 2025-04-29 | 2024-11-07 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 |
| Reported EPS | -87.38 | 110.27 | -118.56 | -0.482 | -0.4836 | -0.1157 | -0.1133 | -0.5099 | -0.5121 | -0.0442 | -0.0444 | 0.0596 |
| Estimated EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Surprise | -87.38 | 110.27 | -118.56 | -0.482 | -0.4836 | -0.1157 | -0.1133 | -0.5099 | -0.5121 | -0.0442 | -0.0444 | 0.0596 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MRM
2026-02-04 07:58:40
MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) shares have dropped 26% in the last month, yet are still up 54% over the past year. Despite a low price-to-sales (P/S) ratio of 0.2x compared to the industry average of 1.3x, the company's revenue growth, while respectable at 13% over the last year and 25% over three years, has not translated into a higher P/S, suggesting investor caution. This article suggests there might be unobserved threats to revenue, despite the company's recent performance aligning with industry growth expectations.
2026-01-31 05:57:22
MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) has a low price-to-sales (P/S) ratio of 0.2x compared to the industry average of 1.3x, which might signal a buying opportunity. Despite recent revenue growth aligning with industry expectations, the P/S ratio suggests potential risks are depressing the share price. The article advises investors to consider these risks despite the seemingly undervalued P/S ratio.
2026-01-30 10:31:26
MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) has a low price-to-sales (P/S) ratio of 0.2x compared to the industry average of 1.3x, which might suggest it's undervalued. However, the low P/S ratio could be due to investor concerns about its future performance, despite recent revenue growth. While the company's three-year revenue growth is similar to industry expectations, its low P/S ratio indicates that potential risks might be weighing on its share price.
2026-01-23 22:10:00
MEDIROM Healthcare Technologies Inc. has announced a Master Service Agreement with Tools for Humanity and the World Foundation to facilitate the adoption of World ID across Japan. The partnership involves installing Orb authentication terminals, which verify unique human identity for a secure digital ID, at approximately 3,000 locations nationwide. This expansion will leverage MEDIROM's "Re.Ra.Ku" wellness centers and collaborations with various other retail and service providers.
2026-01-23 21:57:51
MEDIROM (NASDAQ: MRM) has partnered with Tools for Humanity and the World Foundation to significantly expand World ID adoption in Japan. The agreement involves deploying World ID Orbs to approximately 3,000 locations nationwide, starting with existing MEDIROM Group wellness centers and expanding to Re.Ra.Ku salons and other third-party locations. This move aims to promote the World ID system, which allows individuals to verify their unique humanity.
2026-01-23 21:57:51
MEDIROM Healthcare Technologies (MRM) has signed a major Master Service Agreement with Tools for Humanity and the World Foundation to significantly expand the adoption of World ID in Japan. This deal involves deploying Orb biometric authentication devices across approximately 3,000 locations nationwide, leveraging MEDIROM's Re.Ra.Ku wellness salons and a broader partner network. Despite strong revenue growth, analytics highlight profitability and liquidity challenges for MRM, with a current analyst rating of Hold and a $2.00 price target.
